Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Oruka Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +24 vs. Q2 2025
- Shares held
- 45.6M
- +11.1M (+32.3%) vs. Q2 2025
- Total value
- $875.8M
- +$489.9M (+126.9%) vs. Q2 2025
- New holders
- 32
- 31 more added
- Sold out
- 8
- 22 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORKA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 255 | $7.05B |
| Q1 2026 | 184 | $2.55B |
| Q4 2025 | 143 | $1.60B |
| Q3 2025 | 105 | $875.8M |
| Q2 2025 | 81 | $386.0M |
| Q1 2025 | 71 | $326.1M |
| Q4 2024 | 66 | $606.6M |
| Q3 2024 | 42 | $604.2M |
| Q2 2024 | 32 | $49.4M |
| Q1 2024 | 23 | $12.7M |
| Q4 2023 | 25 | $12.7M |
| Q3 2023 | 21 | $6.55M |
| Q2 2023 | 23 | $5.75M |
| Q1 2023 | 26 | $5.02M |
| Q4 2022 | 22 | $6.19M |
| Q3 2022 | 25 | $4.58M |
| Q2 2022 | 24 | $4.17M |
| Q1 2022 | 22 | $2.60M |
| Q4 2021 | 21 | $2.41M |
| Q3 2021 | 19 | $4.53M |
| Q2 2021 | 17 | $4.16M |
| Q1 2021 | 17 | $3.20M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Oruka Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 6 | $115 | 0.00% | +4+200.0% | Added |
| Allworth Financial LP | 5 | $97 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 3 | $58 | 0.00% | +3 | New |
| Advisor Group Holdings, Inc. | 1 | $19 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 1 | $19 | 0.00% | +1 | New |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −583,327−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −165,389−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −68,574−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −33,962−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −19,003−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −12,326−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |